A randomized trial shows dose-frequency and genotype may determine the therapeutic efficacy of intranasal oxytocin

Juan Kou, Yingying Zhang, Feng Zhou, Cornelia Sindermann, Christian Montag, Benjamin Becker, Keith M Kendrick
doi: https://doi.org/10.1101/2020.08.23.20180489

Article usage

Article usage: August 2020 to July 2025

AbstractFullPdf
Aug 2020195030
Sep 2020135065
Oct 202037040
Nov 202043035
Dec 2020107051
Jan 2021150040
Feb 2021233030
Mar 2021691119
Apr 20217918
May 202173312
Jun 202153210
Jul 202130111
Aug 20212169
Sep 202128117
Oct 202124236
Nov 202120330
Dec 202129024
Jan 202223621
Feb 202222715
Mar 20221426
Apr 202224315
May 202221516
Jun 20221219
Jul 20221313
Aug 202215214
Sep 20222326
Oct 202220216
Nov 2022171914
Dec 20221638
Jan 202313416
Feb 202310421
Mar 20239717
Apr 202322614
May 202310515
Jun 202316713
Jul 2023627
Aug 202315159
Sep 202310812
Oct 2023959
Nov 2023262310
Dec 2023637
Jan 2024946
Feb 2024736
Mar 202411511
Apr 202471613
May 2024643
Jun 20241458
Jul 20241235
Aug 202420810
Sep 202414612
Oct 2024988
Nov 20249413
Dec 20248613
Jan 20256511
Feb 202543310
Mar 2025185820
Apr 2025195820
May 2025148919
Jun 2025242018
Jul 2025121717
Back to top
Posted August 25, 2020.
Download PDF

Supplementary Material

Data/Code
Email
A randomized trial shows dose-frequency and genotype may determine the therapeutic efficacy of intranasal oxytocin
Juan Kou, Yingying Zhang, Feng Zhou, Cornelia Sindermann, Christian Montag, Benjamin Becker, Keith M Kendrick
medRxiv 2020.08.23.20180489; doi: https://doi.org/10.1101/2020.08.23.20180489
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area